# Dong-A University Hospital

Organization · id `cardio:org-dong-a-university-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 05gcxpk23](<https://ror.org/05gcxpk23>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 05gcxpk23 by an exact name.

## The registry's words

- Sponsor name: Dong-A University Hospital
- Sponsor class: OTHER
- ROR name: Dong-A University Hospital

## Connected pages

- Sponsors: to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia (`cardio:ct-nct02056847`)
- Sponsors: Fimasartan/Amlodipine Combination Phase III (`cardio:ct-nct02152306`)
- Sponsors: Edoxaban Versus Apixaban in Cancer-Associated Venous Thromboembolism (`cardio:ct-nct07852637`)

## Provenance

Content hash: bd9021827bc30c8a101ded1c6c455dd64030fd47978090d3f15f0877408665f2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
